Lazard Asset Management LLC
- SEC CIK
- 0001207017
- Latest filing
- Aug 14, 2026
BBIO holding history
BridgeBio Pharma, Inc. in every 13F filed by Lazard Asset Management LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
BBIO overviewAll 13F holders of BBIOFull Q2 2026 holdings
- Shares (Q2 2026)
- 8,374
- Value
- $623.7K
- % of portfolio
- <0.1%
- Quarters held
- 13
- Since Q3 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 8,374 | $623.7K | <0.1% | +953+12.8% | Added | Holders |
| Q1 2026 | 7,421 | $551.1K | <0.1% | +6,181+498.5% | Added | Holders |
| Q4 2025 | 1,240 | $94.8K | <0.1% | +426+52.3% | Added | Holders |
| Q3 2025 | 814 | $42.3K | <0.1% | +814 | New | Holders |
| Q4 2024 | 0 | $0 | 0.0% | −38−100.0% | Sold out | Holders |
| Q3 2024 | 38 | $0 | 0.0% | −3,867−99.0% | Reduced | Holders |
| Q2 2024 | 3,905 | $98.0K | <0.1% | +3,905 | New | Holders |
| Q2 2023 | 0 | $0 | 0.0% | −12,292−100.0% | Sold out | Holders |
| Q1 2023 | 12,292 | $203.0K | <0.1% | −63,309−83.7% | Reduced | Holders |
| Q4 2022 | 75,601 | $576.0K | <0.1% | −24,076−24.2% | Reduced | Holders |
| Q3 2022 | 99,677 | $990.0K | <0.1% | +74,255+292.1% | Added | Holders |
| Q2 2022 | 25,422 | $230.0K | <0.1% | −6,455−20.2% | Reduced | Holders |
| Q1 2022 | 31,877 | $323.0K | <0.1% | +12,870+67.7% | Added | Holders |
| Q4 2021 | 19,007 | $317.0K | <0.1% | +18,025+1,835.5% | Added | Holders |
| Q3 2021 | 982 | $46.0K | <0.1% | +982 | New | Holders |